Literature DB >> 1704496

Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.

N R Lemoine1, S Staddon, J Bond, F S Wyllie, J J Shaw, D Wynford-Thomas.   

Abstract

We have previously shown that activation of ras oncogenes by mutation is a frequent early event in human thyroid neoplasia. Using amphotropic retroviral vectors to achieve gene transfer, we demonstrate here that human primary thyroid epithelial cells can be partially transformed by an activated cellular or viral Ha-ras oncogene, in the absence of a cooperating oncogene. The transformation event induced by ras involves temporary rescue from senescence for up to 20 rounds of cell division together with morphological alteration, growth factor independence and anchorage independence. It has therefore been possible to reconstruct in vitro a key early event in the genesis of human epithelial neoplasia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704496

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.

Authors:  Chiara Laezza; Gherardo Mazziotti; Laura Fiorentino; Patrizia Gazzerro; Giuseppe Portella; Diego Gerbasio; Carlo Carella; Giuseppe Matarese; Maurizio Bifulco
Journal:  J Mol Med (Berl)       Date:  2006-09-01       Impact factor: 4.599

2.  Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.

Authors:  O M Tsygankova; A Saavedra; J F Rebhun; L A Quilliam; J L Meinkoth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Activation of endothelial ras signaling bypasses senescence and causes abnormal vascular morphogenesis.

Authors:  Anshika Bajaj; Qingxia Zheng; Alejandro Adam; Peter Vincent; Kevin Pumiglia
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

4.  Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase.

Authors:  E Kupperman; W Wen; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells.

Authors:  C J Jones; D Kipling; M Morris; P Hepburn; J Skinner; A Bounacer; F S Wyllie; M Ivan; J Bartek; D Wynford-Thomas; J A Bond
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Role of epidermal growth factor receptor signaling in RAS-driven melanoma.

Authors:  Nabeel Bardeesy; Minjung Kim; Jin Xu; Ryung-Suk Kim; Qiong Shen; Marcus W Bosenberg; Wing H Wong; Lynda Chin
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  Differential effects of protein kinase A on Ras effector pathways.

Authors:  M J Miller; L Rioux; G V Prendergast; S Cannon; M A White; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

8.  Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

Authors:  M F Di Renzo; M Olivero; G Serini; F Orlandi; S Pilotti; A Belfiore; A Costantino; R Vigneri; A Angeli; M A Pierotti
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.